1. The risk of cancer was higher amongst children of mothers with epilepsy who were exposed to high-dose folic acid...
1. 25.8% of patients receiving chemotherapy for breast cancer experienced worsening frailty status. 2. Patients with both biomarkers (IL-6 and...
1. Patients in the active surveillance group who had forgone surgery had no difference in survival compared to patients who...
1. Objective response rate was 43.9%. Patients treated with selpercatinib also experienced improved overall response and time on treatment than...
1. Selpercatinib was found to have similar effective objective response rates compared to past studies in both treatment-naïve and chemotherapy...
1. Patients who had never previously received anti-angiogenesis treatments had longer progression-free survival 2. Adverse events of combination avelumab and...
1. Hepatocellular carcinoma (HCC) tumours located in ultrasound (US) blind spots were associated with poorer overall survival if not detected...
1. After neoadjuvant treatment with celmiplimab, half of the patients were found to have a complete pathological response 2. Almost...
1. Adjuvant pembrolizumab significantly improved disease-free survival in comparison to placebo in PD-L1 unselected non-small-cell lung cancer patients who underwent...
1. Telaglenastat addition to cabozantinib did not show improvements in clinical benefit. 2. Adverse events of grades 3 or 4...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.